SS
Savita Singh
About Savita Singh
Data last updated:
Savita Singh is a Director at Flaxelle Medicare Private Limited (since 2020) and Director at 7Series Buildwell Private Limited (since 2023). The companies operate in Chemicals. The largest current company by reported revenue is Flaxelle Medicare Private Limited at ₹18 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Flaxelle Medicare Private Limited U24100DL2020PTC361491 | Director | 06 Feb 2020 | 2020 | ₹18 Lakh (FY 2023) | Active |
| 7Series Buildwell Private Limited U43299UP2023PTC180023 | Director | 12 Apr 2023 | 2023 | Active |
Board colleagues of Savita Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandra Bhan Singh | 08917681 | Flaxelle Medicare Private Limited | Additional Director |
| Pravesh Kumar Singh | 08691511 | 7Series Buildwell Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Savita Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Savita Singh
Savita Singh currently holds 2 directorships: Flaxelle Medicare Private Limited (Director, since 06 Feb 2020, revenue ₹18 Lakh (FY 2023)); 7Series Buildwell Private Limited (Director, since 12 Apr 2023).
Savita Singh was first appointed on 06 Feb 2020 as Director at Flaxelle Medicare Private Limited. The most recent appointment on record is 12 Apr 2023 at 7Series Buildwell Private Limited.
The current boards of Savita Singh's companies include Chandra Bhan Singh (Flaxelle Medicare Private Limited), Pravesh Kumar Singh (7Series Buildwell Private Limited).